BERLIN--(BUSINESS WIRE)--BIOTRONIK a leading manufacturer of innovative medical technology, announced today the first implantation of the new Lumax 740 ICD (implantable cardiac defibrillator) in Hong Kong. Lumax 740 is the world’s first and only ICD and CRT-D series approved for magnetic resonance imaging (MRI)1, now giving ICD and CRT-D patients access to vital MR scans with BIOTRONIK’s innovative ProMRI® technology. This combined with the product’s extended device longevity and BIOTRONIK Home Monitoring®, brings the Lumax 740 series to the forefront of cardiac devices for patients with tachyarrhythmias.
